Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedikt Feuerecker

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Metabolites|June 2, 2021
Metabolic Response of Pancreatic Carcinoma Cells under Treatment with DichloroacetateBenedikt Feuerecker, Philipp Biechl, Christian Veltkamp, et al.
Leukemia & Lymphoma|November 3, 2020
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces <sup>18</sup>F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosisGabriel Buschner, Benedikt Feuerecker, Sabine Spinner, et al.
American Journal of Cancer Research|May 15, 2015
DCA promotes progression of neuroblastoma tumors in nude miceBenedikt Feuerecker, Christof Seidl, Sabine Pirsig, et al.
Translational Andrology and Urology|November 22, 2021
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancerLukas Lunger, Robert Tauber, Benedikt Feuerecker, et al.
Scientific Reports|June 6, 2019
Assessment of <sup>213</sup>Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-<sup>13</sup>C]pyruvate and [<sup>18</sup>F]FDGBenedikt Feuerecker, Michael Michalik, Christian Hundshammer, et al.
Scientific Reports|March 19, 2021
Diverse metabolic response of cancer cells treated with a <sup>213</sup>Bi-anti-EGFR-immunoconjugateBenedikt Feuerecker, Philipp Biechl, Christof Seidl, et al.
Cancer Biology & Therapy|September 8, 2012
Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivoBenedikt Feuerecker, Sabine Pirsig, Christof Seidl, et al.
American Journal of Cancer Research|July 16, 2015
Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cellsHans-Richard Demel, Benedikt Feuerecker, Guido Piontek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
Journal of Cancer|September 21, 2017
Hyperpolarized <sup>13</sup>C Diffusion MRS of Co-Polarized Pyruvate and Fumarate to Measure Lactate Export and NecrosisBenedikt Feuerecker, Markus Durst, Michael Michalik, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Metabolites|June 2, 2021
Metabolic Response of Pancreatic Carcinoma Cells under Treatment with DichloroacetateBenedikt Feuerecker, Philipp Biechl, Christian Veltkamp, et al.
Leukemia & Lymphoma|November 3, 2020
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces <sup>18</sup>F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosisGabriel Buschner, Benedikt Feuerecker, Sabine Spinner, et al.
American Journal of Cancer Research|May 15, 2015
DCA promotes progression of neuroblastoma tumors in nude miceBenedikt Feuerecker, Christof Seidl, Sabine Pirsig, et al.
Translational Andrology and Urology|November 22, 2021
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancerLukas Lunger, Robert Tauber, Benedikt Feuerecker, et al.
Scientific Reports|June 6, 2019
Assessment of <sup>213</sup>Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-<sup>13</sup>C]pyruvate and [<sup>18</sup>F]FDGBenedikt Feuerecker, Michael Michalik, Christian Hundshammer, et al.
Scientific Reports|March 19, 2021
Diverse metabolic response of cancer cells treated with a <sup>213</sup>Bi-anti-EGFR-immunoconjugateBenedikt Feuerecker, Philipp Biechl, Christof Seidl, et al.
Cancer Biology & Therapy|September 8, 2012
Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivoBenedikt Feuerecker, Sabine Pirsig, Christof Seidl, et al.
American Journal of Cancer Research|July 16, 2015
Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cellsHans-Richard Demel, Benedikt Feuerecker, Guido Piontek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
Journal of Cancer|September 21, 2017
Hyperpolarized <sup>13</sup>C Diffusion MRS of Co-Polarized Pyruvate and Fumarate to Measure Lactate Export and NecrosisBenedikt Feuerecker, Markus Durst, Michael Michalik, et al.
Pageof 4